Hydroxyzine pamoate

恩波酸羟嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameHydroxyzine pamoate
Drug Alias NameHydroxyzine Embonate双羟萘酸vistaril
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsAnxiety DisordersPruritus
Global Approved IndicationsAnxiety DisordersPruritus
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1959/06/03
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsAnxiety DisordersPruritus

Other Information

ATC CodeN05BB01
Related LinksWikipediaDrugBankKEGG